Skip to main content

Asian shares mixed amid cautious outlook for global economy

Sunday, April 18, 2021 | Yuri Kageyama, AP Business Writer


Pedestrians pass the New York Stock Exchange, Wednesday, Jan. 27, 2021, in New York. Stocks are opening higher on Wall Street, keeping the S&P 500 on track for its fourth weekly gain in a row. The benchmark index was up 0.3% in the early going Friday, April 16, led by gains in banks, industrial and health care companies. (AP Photo/John Minchillo, File)

TOKYO (AP) — Asian shares were mixed Monday amid cautious optimism about a global rebound from the coronavirus pandemic.

Japan's benchmark quickly lost early gains and fell 0.1% to 29,642.79, the first market reaction after a summit by Prime Minister Yoshihide Suga with President Joe Biden over the weekend. Suga also spoke with the Pfizer chief executive, asking to ensure a more steady supply of the company's COVID-19 vaccine. Japan has lagged other nations in a vaccine rollout, with barely 1% of its population inoculated so far.

The government measures against COVID-19 infections already in some urban areas, including Tokyo, are being expanded to more parts of Japan, starting Tuesday, but the cities of Tokyo and Osaka are considering strengthening them to a “state of emergency.” Japan has never had a lockdown, and its laws would need to be changed for such action.

Australia's S&P/ASX 200 gained 0.4% to 7,093.20, while South Korea's Kospi added 0.4% to 3,212.41. Hong Kong's Hang Seng lost 0.4% to 28,856.21. The Shanghai Composite inched down 0.1% to 3,421.96.

Yoshimasa Maruyama, chief market economist at SMBC Nikko Securities, said that although the promised vaccine after Suga's U.S. visit works as a plus for Japan, their agreement to take a stiffer stance on China adds to investor worries because of China's importance for the Japanese economy.

Suga likely had hoped Biden would more forcefully expressed his support for the Tokyo Olympics, set to open in July, despite widespread public worries about the pandemic and opposition to holding the Games. The joint statement refers to the U.S. support for Japan's "efforts to hold a safe and secure" Games.

“The Suga administration has taken a risk in China relations, in accordance to the U.S. request,” Maruyama said.

On Wall Street, the S&P 500 and Dow Jones Industrial Average ended last week with new highs. The S&P 500 rose 15.05 points, or 0.4%, to 4,185.47, led by gains in companies that rely directly on consumer spending, health care stocks and banks, which benefited from higher Treasury yields.

The Dow gained 164.68 points, or 0.5% to 34,200.67. The S&P and Dow also hit all-time highs on Thursday. The technology-heavy Nasdaq inched up 13.58 points, or 0.1%, to 14,052.34 after recovering from an early slide. The Russell 2000 index of smaller companies added 5.60 points, or 0.2%, to 2,262.67.

U.S. stocks have rallied in recent weeks amid a string of encouraging reports on hiring, consumer confidence and spending that point to an accelerating U.S. economy. COVID-19 vaccinations, now reaching half of the U.S. population, and massive support from the U.S. government and Federal Reserve are fueling expectations for solid corporate profit growth as more businesses reopen.

The last round of stimulus from the government helped lift retail sales, and investors now have to weigh other proposals in Washington, which include investments in infrastructure and potential tax changes.

Investors are also focusing on the global economic recovery. Earnings reporting season is approaching, and expectations are high for companies to show they are recovering from the pandemic. Dozens of U.S. companies are report results this week, including Coca-Cola, Johnson & Johnson, Verizon Communications, Dow Chemical and American Airlines.

In energy trading, benchmark U.S. crude fell 35 cents to $62.78 a barrel. Brent crude the international standard fell 43 cents to $66.34 a barrel.

In currency trading, the U.S. dollar edged down to 108.74 Japanese yen from 108.86 yen. The euro cost $1.957, down from $1.1978.

Featured Article: CAC 40 Index


7 Things You Need To Know About Cryptocurrency

The Cryptocurrency Market Is About To Boil Over

The cryptocurrency was quiet for years, but it’s starting to boil over once again. With the price of Bitcoin up 550%, it certainly seems like the sky is the limit.

Whether or not you choose to trade Bitcoin or any other cryptocurrency, it is important to understand what it is and the trends driving it.

The bottom line, however, is that the world’s money is flowing onto the blockchain, and the use of cryptocurrency is growing at an exponential rate.

View the "7 Things You Need To Know About Cryptocurrency".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)2.1$39.69+0.9%3.93%25.61Hold$39.64
Johnson & Johnson (JNJ)2.5$168.20-0.4%2.40%26.45Buy$185.70
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.